1. Cost Estimates and Economic Implications of Expanded RAS Testing in Metastatic Colorectal Cancer. (19th November 2014) Authors: Kircher, Sheetal M.; Mohindra, Nisha; Nimeiri, Halla Journal: Oncologist Issue: Volume 20(2015)Supplement 1 Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Early circulating tumor DNA dynamics as a pan‐tumor biomarker for long‐term clinical outcome in patients treated with durvalumab and tremelimumab. Issue 2 (13th December 2022) Authors: Kansara, Maya; Bhardwaj, Neeru; Thavaneswaran, Subotheni; Xu, Chang; Lee, Jessica K.; Chang, Lo‐Bin; Madison, Russell W.; Lin, Frank; Hsu, Eugene; Patel, Vipul Kumar; Aleshin, Alexey; Oxnard, Geoffrey R.; Simes, John; Nimeiri, Halla; Thomas, David M. Journal: Molecular oncology Issue: Volume 17:Issue 2(2023) Page Start: 298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ERBB2 Copy Number as a Quantitative Biomarker for Real-World Outcomes to Anti–Human Epidermal Growth Factor Receptor 2 Therapy in Advanced Gastroesophageal Adenocarcinoma. (20th January 2022) Authors: Zhang, Liangliang; Hamdani, Omar; Gjoerup, Ole; Cho-Phan, Cheryl; Snider, Jeremy; Castellanos, Emily; Nimeiri, Halla; Frampton, Garrett; Venstrom, Jeffrey M.; Oxnard, Geoffrey; Klempner, Samuel J.; Schrock, Alexa B. Journal: JCO precision oncology Issue: Volume 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study. (19th November 2019) Authors: Kamath, Suneel D.; Kalyan, Aparna; Kircher, Sheetal; Nimeiri, Halla; Fought, Angela J.; Benson, Al; Mulcahy, Mary Journal: Oncologist Issue: Volume 25:Number 5(2020) Page Start: e808 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results. Issue 2 (18th August 2022) Authors: Kennecke, Hagen F.; O'Callaghan, Chris J.; Loree, Jonathan M.; Moloo, Hussein; Auer, Rebecca; Jonker, Derek J.; Raval, Manoj; Musselman, Reilly; Ma, Grace; Caycedo-Marulanda, Antonio; Simianu, Vlad V.; Patel, Sunil; Pitre, Lacey D.; Helewa, Ramzi; Gordon, Vallerie L.; Neumann, Katerina; Nimeiri, ... Journal: Journal of clinical oncology Issue: Volume 41:Issue 2(2023) Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. Issue 4 (April 2017) Authors: Morris, Van K; Salem, Mohamed E; Nimeiri, Halla; Iqbal, Syma; Singh, Preet; Ciombor, Kristen; Polite, Blase; Deming, Dustin; Chan, Emily; Wade, James L; Xiao, Lianchun; Bekaii-Saab, Tanios; Vence, Luis; Blando, Jorge; Mahvash, Armeen; Foo, Wai Chin; Ohaji, Chimela; Pasia, Manolo; Bland, Gail; Ohi... Journal: Lancet oncology Issue: Volume 18:Issue 4(2017:Apr.) Page Start: 446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5‐fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 32041. Issue 8 (3rd January 2013) Authors: Landry, Jerome C.; Feng, Yang; Cohen, Steven J.; Staley, Charles A.; Whittington, Richard; Sigurdson, Elin Ruth; Nimeiri, Halla; Verma, Udit; Prabhu, Roshan S.; Benson, Al Bowen Journal: Cancer Issue: Volume 119:Issue 8(2013) Page Start: 1521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5‐fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 32041. Issue 8 (3rd January 2013) Authors: Landry, Jerome C.; Feng, Yang; Cohen, Steven J.; Staley, Charles A.; Whittington, Richard; Sigurdson, Elin Ruth; Nimeiri, Halla; Verma, Udit; Prabhu, Roshan S.; Benson, Al Bowen Journal: Cancer Issue: Volume 119:Issue 8(2013) Page Start: 1521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204. (29th April 2015) Authors: Landry, Jerome C.; Feng, Yang; Prabhu, Roshan S.; Cohen, Steven J.; Staley, Charles A.; Whittington, Richard; Sigurdson, Elin Ruth; Nimeiri, Halla; Verma, Udit; Benson, Al Bowen Journal: Oncologist Issue: Volume 20:Number 6(2015) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5‐Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5‐Year Clinical Outcomes ECOG‐ACRIN Cancer Research Group E3204. (29th April 2015) Authors: Landry, Jerome C.; Feng, Yang; Prabhu, Roshan S.; Cohen, Steven J.; Staley, Charles A.; Whittington, Richard; Sigurdson, Elin Ruth; Nimeiri, Halla; Verma, Udit; Benson, Al Bowen Journal: Oncologist Issue: Volume 20:Number 6(2015) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗